glp-1 drugs fda approved medicare part d coverage 2025 covers GLP-1s for $50/month starting July 2026 GLP-1 Weight-Loss Drug Demonstration Begins

doi: 10.1056/NEJMoa2208601

Despite a significant number of bills in 2023 and 2024 that would have required mandated coverage of GLP-1s in Medicaid, state employee health plans, or for health insurers regulated by the state, only Arkansas, California, Maryland, New Mexico, Pennsylvania, and Texas have introduced legislation mandating coverage in 2025 to date

Nevertheless, liver function tests are still recommended and vildagliptin is not approved for use in patients with hepatic insufficiency

Malatt C, Wu T, Bresee C, Hogg E, Wertheimer J, Tan E, Pomeroy H, Obialisi G, Tagliati M

When people say my metabolism is broken, they actually mean Im constantly hungry and cant maintain weight loss through willpower alone. Thats hormone dysregulation, not metabolic damage, and it gradually normalizes over time or with medication resumption

The growth in the forecast period can be attributed to growing obesity population, expanding approval for cardiovascular risk reduction, innovation in oral and combination therapies, increased penetration in emerging markets, rising patient preference for weight loss benefits